SNP | Group | N | Genotype (%) | Â | Â | P | Allele (%) | Â | P |
---|---|---|---|---|---|---|---|---|---|
Exon1+179 (rs13306114) | C/C | C/C | C/T | Â | T/T | C | T | ||
 | Control | 229 | 229 (100.0%) | 0 (0.0%) | 0 (0.0%) |  | 458 (100.0%) | 0 (0.0%) |  |
 | METH | 171 | 168 (98.2%) | 3 (1.8%) | 0 (0.0%) | 0.132 | 339 (99.1%) | 3 (0.9%) | 0.154 |
Exon1+219 | C/C | C/T | T/T | Â | C | T | Â | ||
 | Control | 229 | 228 (99.6%) | 1 (0.4%) | 0 (0.0%) |  | 457 (99.8%) | 1 (0.2%) |  |
 | METH | 171 | 169 (98.8%) | 2 (1.2%) | 0 (0.0%) | 0.701 | 340 (99.4%) | 2 (0.6%) | 0.807 |
IVS1+64 (rs13306116) | G/G | G/A | A/A | Â | G | A | Â | ||
 | Control | 229 | 219 (95.6%) | 10 (4.4%) | 0 (0.0%) |  | 448 (97.8%) | 10 (2.2%) |  |
 | METH*1 | 171 | 162 (94.7%) | 8 (4.7%) | 1 (0.6%) | 0.504 | 332 (97.1%) | 10 (2.9%) | 0.663 |
Exon2+751 (rs5751876) | T/T | T/C | C/C | Â | T | C | Â | ||
 | Control | 229 | 70 (30.6%) | 114 (49.8%) | 45 (19.7%) |  | 254 (55.5%) | 204 (44.5%) |  |
 | METH | 171 | 35 (20.5%) | 85 (49.7%) | 51 (29.8%) | 0.018 | 155 (45.3%) | 187 (54.7%) | 0.0057 |
IVS2+28 (rs34923252) | T/T | T/A | A/A | Â | T | A | Â | ||
 | Control | 229 | 181 (79.0%) | 43 (18.8%) | 5 (2.2%) |  | 405 (88.4%) | 53 (11.6%) |  |
 | METH | 171 | 144 (84.2%) | 26 (15.2%) | 1 (0.6%) | 0.258 | 314 (91.8%) | 28 (8.2%) | 0.146 |